Press Room

There are 3 item(s) tagged with the keyword "Continuous Glucose Monitoring (CGM)".

1. JDRF Announces Two Partnerships to Develop Stable, Pumpable Glucagon to Support Advanced Generation Artificial Pancreas Systems

JDRF announced today partnerships with both Xeris Pharmaceuticals, Inc., and LATITUDE Pharmaceuticals, Inc. (LPI), to support the development soluble glucagon formulations—an important step toward the advancement of future generation, fully automated and multi-hormonal ...


2. JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes

JDRF and BD (Becton, Dickinson and Company) (NYSE:BDX) are accelerating the development of new products that combine BD’s proprietary insulin infusion and glucose sensing technologies through a new collaboration announced today.


3. New Study Aims to Increase Adoption of Advanced Diabetes Technology in Young People with T1D

Ottawa, ON (November 3, 2011) – JDRF Canadian Clinical Trial Network (JDRF CCTN) is pleased to announce the launch of the first multi-centre pediatric study in Canada using insulin pump therapy and continuous glucose monitoring (CGM). Based at the Children’s Hospital of Eastern Ontario (CHEO) ...


Lets turn type one into type none